Exercise: Clinical Trials

164 trials of Exercise, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

164 completed. 164 Phase 2, 24 Phase 3, 17 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 2164Completed 164
Phase 324Completed 24
Phase 117Completed 17

Follow Exercise: new trials by email Literature Review of Exercise trials Research Report on Exercise

Trials (filtered) newest first · largest first

All 164 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Impact of LLL and Aerobic Exercise on Peripheral Arterial Outcomes in Patients With Type 2 Diabetes
aerobic exercise + low-level laser therapy, Aerobic exercise - Type 2 Diabetes Mellitus (T2DM)
Phase 2CompletedNouran Hesham Slama Younis402025-02-202025-08-19
Fitness After Stroke Trial
Exercise MICT, Exercise HIIT - Stroke, Stroke, Ischemic
Phase 2CompletedUniversity of Kansas Medical Center592023-07-032026-01-06
The Lived Experiences Measured Using Rings Pilot Study
Moodlifters, Physical Activity, Nature Experiences - Depression, Stress
Phase 2CompletedUniversity of Vermont1882022-12-012025-04-17
Effect of Aerobic Training and Ginkgo Biloba on Lipids Levels in HIV-positive Patients Undergoing Antiretroviral Treatment
Aerobic exercise + Ginkgo Biloba Extract, Aerobic exercise + Calcined magnesia (placebo), Aerobic exercise + Atorvastatin - Human Immunodeficiency Virus
Phase 2 / Phase 3CompletedUniversity of Guadalajara282022-05-012024-05-08
Slow Age: Interventions to Slow Aging in Humans
Exercise, Time restricted feeding, Nicotinamide riboside - Aging
Phase 2CompletedUniversity of Copenhagen802022-05-012023-04-25
Feasibility of Home-based Exercise Program for Adults With Cystic Fibrosis
Xenon MRI - Cystic Fibrosis
Phase 2CompletedUniversity of Kansas Medical Center212022-03-152025-06-12
The Acute Effects of Exercise and Caffeine on Working Memory During Acute Caffeine Deprivation
Acute Exercise, Caffeine Powder - Acute Exercise, Caffeine Withdrawal
Phase 2 / Phase 3CompletedWestern University, Canada72022-01-102024-03-04
Exercise Plus Duloxetine for Knee Osteoarthritis
Aerobic exercise, Duloxetine - Knee Osteoarthritis, Depression
Phase 2CompletedUniversity of Maryland, Baltimore432021-10-072026-10-29
Corticosteroid Effects on Asymptomatic Gadolinium-enhancing Lesions in Multiple Sclerosis
Methylprednisolone succinate, Normal saline - Multiple Sclerosis, Relapsing-Remitting, Magnetic Resonance Imaging
Phase 2CompletedMazandaran University of Medical Sciences1022021-05-222025-07-15
Type 2 Diabetes Mellitus Prevention Ukraine
Physical activity, Macronutrient modification - Impaired Fasting Glucose, Impaired Glucose Tolerance
Phase 2CompletedKomisarenko Institute of Endocrinology and Metobolism302020-02-202022-08-26
A Study to Evaluate LB1148 for Return of Gastrointestinal Function and Adhesions in Subjects Undergoing Bowel Resection
LB1148, Placebo - Ileus, Post-Operative Adhesions
Phase 2CompletedPalisade Bio1122019-10-012024-06-21
Gut Imaging for Function & Transit in Cystic Fibrosis Study 2
Tezacaftor/Ivacaftor + Ivacaftor, Placebo oral tablet - Cystic Fibrosis
Phase 2CompletedNottingham University Hospitals NHS Trust122019-09-032023-05-24
Saline Injections vs Education and Exercise in Knee Osteoarthritis
GLA:D, Intra-articular saline injection - Osteoarthritis, Knee
Phase 2CompletedMarius Henriksen2062019-08-052020-12-22
ACES - ACE Inhibitors Combined With Exercise for Seniors With Hypertension
Aerobic exercise, Perindopril, Losartan - Hypertension, Aging
Phase 2CompletedUniversity of Alabama at Birmingham2232018-05-292025-07-22
Physical Activity Monitored by Fitbit Charge 2 in Improving Quality of Life in Participants With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Laboratory Biomarker Analysis, Monitoring Device, Physical Activity - Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Neoplasm
Phase 2CompletedRoswell Park Cancer Institute92017-06-272021-09-02
A Trial of a Botanical Drug (EISO) for Treatment of Mild-to-Moderate Plaque Psoriasis
SAN021 Serum, SAN021 Placebo - Plaque Psoriasis
Phase 2CompletedSantalis Pharmaceuticals, Inc.692017-05-172019-05-29
Prevention of Comorbid Depression and Obesity in Attention-deficit/ Hyperactivity Disorder
Bright light therapy, Physical exercise - Attention-Deficit / Hyperactivity Disorder, Depression
Phase 2CompletedGoethe University2072017-03-132020-10-19
Omega-3 Fatty Acids and Exercise on Mobility and Cognition in Older Women
Efamol Active 50+, Aerobic exercise, Placebo multinutrient - Aging, Cognitive Decline
Phase 2CompletedBournemouth University602017-02-262019-01-16
Efficacy Study in Patients With Acne Vulgaris.
ADPS topical product, Placebo Control - Acne Vulgaris
Phase 2CompletedSun Pharmaceutical Industries, Inc.2942016-10-032018-10-18
An Open Label, Safety Study to Assess the Potential for Adrenal Suppression
DSXS topical - Plaque Psoriasis
Phase 2CompletedSun Pharmaceutical Industries, Inc.162016-09-022018-12-06

Showing 20 of 164. Sign in to see all of them.

Conditions studied

Motor Activity (61)  ·  Obesity (17)  ·  Cardiovascular Diseases (13)  ·  Breast Neoplasms (9)  ·  Insulin Resistance (9)  ·  Heart Diseases (7)  ·  Diabetes Mellitus (6)  ·  Diabetes Mellitus, Type 2 (6)  ·  Hypertension (6)  ·  Depression (5)  ·  Fibromyalgia (5)  ·  Kidney Failure, Chronic (5)  ·  Metabolic Syndrome (5)  ·  Weight Loss (5)  ·  Dermatitis, Atopic (4)

Sponsors

Sun Pharmaceutical Industries, Inc. (9)  ·  National Heart, Lung, and Blood Institute (NHLBI) (6)  ·  Duke University (5)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (4)  ·  Vanderbilt University (4)  ·  Institut de Recherches Cliniques de Montreal (3)  ·  Kaiser Permanente (3)  ·  Northwestern Health Sciences University (3)  ·  Stanford University (3)  ·  University Health Network, Toronto (3)  ·  University of Wisconsin, Madison (3)  ·  AHS Cancer Control Alberta (2)  ·  Bristol-Myers Squibb (2)  ·  Brown University (2)  ·  Butler Hospital (2)

Countries

United States (91)  ·  Canada (18)  ·  Denmark (5)  ·  Germany (5)  ·  Spain (5)  ·  United Kingdom (5)  ·  Norway (4)  ·  Mexico (3)  ·  Netherlands (3)  ·  Brazil (2)  ·  Sweden (2)  ·  Australia (1)  ·  China (1)  ·  Egypt (1)  ·  France (1)

Top investigators

Alp Ikizler, MD (4)  ·  Shabbir MH Alibhai, MD, MSc (3)  ·  Eileen G. Collins, PhD RN (2)  ·  Gert Bronfort, DC, PhD (2)  ·  Harry Prapavessis, PhD (2)  ·  Thomas Buford, PhD (2)  ·  Adam G Tsai, MD, MSCE (1)  ·  Alan Smyth, Prof (1)  ·  Amy Kossert, MHK (1)  ·  Ana Abrantes, PhD (1)  ·  Ana M Abrantes, Ph.D. (1)  ·  Anders Hovland, PsyD (1)  ·  Andrea S Sousa, PhD (1)

Results publications

PMID 25091629, PMID 29976553, PMID 32390133, PMID 33210751, PMID 35018639, PMID 11739090, PMID 12525233, PMID 14655916, PMID 14678952, PMID 15087413, PMID 15159321, PMID 15175588, PMID 15213282, PMID 15229337, PMID 15243275, PMID 15247119, PMID 15247126, PMID 15298949, PMID 15539040, PMID 15556826, PMID 15585547, PMID 15681521, PMID 15824183, PMID 15833948, PMID 15943960, PMID 16232102, PMID 16531889, PMID 16826020, PMID 16909130, PMID 16985018, PMID 17020620, PMID 17071161, PMID 17087620, PMID 17167156, PMID 17287149, PMID 17507612, PMID 17557987, PMID 17855695, PMID 17940108, PMID 18006923, PMID 18155998, PMID 18202351, PMID 18202581, PMID 18403448, PMID 18501061, PMID 18821656, PMID 18923311, PMID 19130989, PMID 19592624, PMID 19928484

NIH funding

R01DK045604 (3), 2009 (1), 2015 (1), K01AG064041 (1), K07CA168886 (1), K23AT001879 (1), K23DA019950 (1), K24DK065018 (1), R01AG018198 (1), R01AR044064 (1), R01AR044724 (1), R01AR045310 (1), R01AT004313 (1), R01AT006970 (1), R01CA134903 (1)